Tendonitis Treatment Market- Growth, Trends, and Forecasts (2023 - 2028)

The tendonitis treatment market size is estimated to register a CAGR of 3.57% during the forecast period 2022-2027.

Over the past few years, sports and physical activities have been increasing, thus increasing the probability of injuries related to these activities, which is driving the tendonitis treatment market.

After the COVID-19 pandemic, care delivery methods for treating tendonitis have altered. Due to temporary lockdowns, travel restrictions, and a high infection load on the healthcare sector, the market value was impacted negatively. The shortage of healthcare professionals for treating tendonitis restrained the development and growth of the market during the COVID-19 pandemic in 2020. The cancellation of sports activities resulted in fewer sports injuries, negatively impacting the tendonitis treatment market.

However, the increasing efforts undertaken by major market players to develop technologically advanced products may contribute to the tendonitis treatment market's growth. For instance, in September 2021, Ossur, a global innovator in prosthetic and non-invasive orthopedic technologies, launched the new Rebound Post-Op Elbow Brace, a non-invasive, lightweight, adjustable brace designed to provide elbow immobilization and range-of-motion restrictions for patients with a variety of conditions, including chronic elbow injuries and tennis elbow release.

The growing adoption of innovative technologies, increased prevalence of the disease in the older population, and increased participation in sporting activities may boost the market's growth over the coming years. However, a lack of awareness about the disease and its advanced treatments among the population may negatively affect the market.

Tendonitis Treatment Market Trends

Tennis Elbow Segment to Dominate the Market by Condition Type

The tennis elbow segment will likely record a high growth rate during the forecast period. New product launches and the availability of cost-effective treatment options are the major growth factors for the tennis elbow segment.

In a study titled, "New Interventional Radiology Treatment for Tennis Elbow Reduces Pain and Inflammation Without Surgery," published in March 2019, 52 patients with tennis elbow who did not find relief from any other treatments were treated with Transcatheter Arterial Embolization (TAE) during 2013-2017 and followed up with for four years after the treatment. The study suggested that a statistically significant rate of pain relief among the patients was found. Images taken of 32 patients two years after undergoing TAE showed an improvement in tendinosis and tear scores. A study published in February 2019 titled "Evidence-based Recommendations for the Management of Anterior Cruciate Ligament (ACL) Rupture" stated that in the US alone, 250,000 individuals suffer an anterior cruciate ligament (ACL) rupture per year, commonly known as ligament tennis elbow. As the tennis elbow segment grows, treatment options are also increasing. Non-invasive therapies are used for tennis elbow treatment. However, the use of braces also gives relief to patients. As per an article published in April 2021 in Orthotexas, tennis elbow can be treated with a bracing program rather than surgery. Hence, major players are focusing on product innovations and boosting the segment's growth.

According to an article titled "Tennis Elbow," published in July 2021, the disease is more common in individuals aged older than 40 years. According to the National Safety Council's (NSC) Injury Facts 2020 report, in the US, bicycling accounted for about 426,000 injuries, the most of any sports and recreation category. Exercise, with or without equipment, followed with about 378,000 injuries. The injuries due to ATV, moped, and minibike were 230,000, and those due to skateboard, scooter, and hoverboard were 218,00, ranking third and fourth. The increasing number of injuries primarily contribute to the tennis elbow segment by condition. The growing number of sports injuries and the prevalence of the disease in the elderly population are expected to boost the market for tennis elbow during the forecast period.

North America Dominates the Market and is Expected to Continue its Dominance Over the Forecast Period

The tendonitis treatment market in North America is expected to dominate the global market due to the presence of major players and higher expenditure on advancements in healthcare. Awareness among people about the disease is growing more in North America compared to other regions. Due to well-established healthcare facilities, the increasing geriatric population, and the growing number of orthopedic procedures, North America is likely to dominate the overall tendonitis treatment market.

According to data from the National Safety Council (NSC), about 130,000 swimming injuries were treated in emergency rooms in 2020, with children under 14 years suffering half of all injuries, according to data from the National Safety Council (NSC). This age group accounted for 45% of soccer injuries, 44% of baseball injuries, and 40% of lacrosse and rugby injuries, treated across emergency rooms in 2020. These increasing number of sports injuries and rising prevalence of diseases like tennis elbow, followed by an increased number of older people with tendonitis, are driving the market's growth in North America.

According to the annual data provided by the US Bureau of Labor Statistics for Employer-Reported Workplace Injuries and Illnesses in 2020, sprains, strains, and tears leading to tendonitis were 266,530, with 1,380 tendonitis patients in the US.

As per another epidemiology study of tennis elbow in US statistics published in March 2021, about 1 in 10 patients suffering from tennis elbow disease with persistent symptoms for more than six months required surgery. However, around 8.5% of patients complained about the recurrence of the disease within two years. Due to the reoccurrence of the disease within two years of diagnosis, the proportion of surgically treated cases tripled from 3.2%. These increasing incidences in the US and other countries in North America are boosting the tendonitis treatment market. Thus, the growing prevalence of tendonitis in the region is expected to contribute to the growth of the tendonitis treatment market during the forecast period.

Tendonitis Treatment Market Competitor Analysis

The tendonitis treatment market report is consolidated. In the current scenario, the number of mergers and acquisitions among market players is increasing, fueling the tendonitis treatment market. The competitive landscape analyzes various business growth strategies adopted by market players. The number of partnerships, agreements, and collaborations among market players is increasing and driving the market value. The major players in the market are engaged in product developments and strategic alliances to cater to the growing global demand and gain a strong position in the market. Major companies profiled in the market report include Teikoku Pharma USA Inc., DJO Global Inc., Zimmer Biomet, 3M, and AKSIGEN.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support